A naturally occurring predatory bacterium can work with the immune system to clear multi-drug resistant Shigella infections in zebrafish.
It is the first time the predatory bacterium Bdellovibrio bacteriovorus has been successfully used as an injected anti-bacterial therapy and represents an important step in the fight against drug-resistant infections, or ‘superbugs’.
Shigella infection is responsible for over 160 million illnesses and over 1 million deaths every year – and is a common cause of ‘travellers’ diarrhoea.’ Cases of drug-resistant Shigella are also on the rise as, although the diarrhoea usually clears up without treatment, antibiotics are often used even in mild cases to stop the diarrhoea faster. Resistance to antibiotics has prompted a team of researchers from Imperial College London and Nottingham University to look to the natural environment for creative solutions to this problem.
‘PREDATORY ACTION’ – ABOUT THE STUDY
To investigate Bdellovibrio’s ability to control drug resistant Gram-negative infections, researchers injected zebrafish larvae with a lethal dose of Shigella flexneri strain M90T which is resistant to both streptomycin and carbenicillin antibiotics. Bdellovibrio was then injected into the larvae’s infection site, and a decrease in the number of Shigella was seen. In the absence of Bdellovibrio, zebrafish were unable to control the replication of Shigella and levels of the bacteria rose.
Co-lead author Dr Serge Mostowy from the Department of Medicine at from Imperial College London said: “This study really shows what a unique and interesting bacterium Bdellovibrio is as it presents this amazing natural synergy with the immune system and persists just long enough to kill prey bacteria before being naturally cleared. It’s an important milestone in research into the use of a living antibiotic that could be used in animals and humans.”
Bdellovibrio can invade and kill a range of Gram-negative bacteria, such as E. coli and Salmonella, in the natural environment. Previous research has shown that it can reduce pathogen numbers in the stomach of chickens when taken as an oral therapy, but there is growing need to develop therapies to target infections in wounds and organs. Successful use of Bdellovibrio highlights its potential uses in tackling a range of drug-resistant Gram-negative bacterial infections that can develop in hospital patients.
The urgent requirement for new antimicrobials calls for increasingly creative solutions
– Dr Alex Willis
Co-lead author from Imperial’s Department of Medicine
Dr Mostowy and co-lead author Dr Alex Willis from the Department of Medicine at Imperial said: “The urgent requirement for new antimicrobials calls for increasingly creative solutions. The zebrafish has been a fantastic model for us to generate rapid understanding of how a living antibiotic can work in an animal. Our findings here provide the basis for testing Bdellovibrio in higher vertebrates and ultimately, humans.
“The translucent zebrafish facilitates powerful microscopy that enables striking understanding more difficult to achieve using other animal models. Being able to visualise the infection as well as the predatory bacteria and host immune cells has been invaluable in helping us understand how Bdellovibrio can function in an animal.”
Professor Liz Sockett, co-lead author from The University of Nottingham said: “This has been a truly ground-breaking collaboration that shows therapeutic Bdellovibrio in action inside the translucent living zebrafish. The predatory action of the Bdellovibrio breaks the Shigella-pathogen cells and this stimulates the white blood cells; redoubling their ‘efforts’ against the pathogen and leading to increased survival of the zebrafish ‘patients’.”
Remarkably, Bdellovibrio is also able to reduce pathogen load in immunocompromised zebrafish larvae that have been depleted of white blood cells. However, survival is significantly greater in immune-competent zebrafish, showing that Bdellovibrio’s maximum therapeutic benefit comes from its ability to work cooperatively with the host’s own immune system.
Dr Michael Chew, Science Portfolio Advisor at Wellcome said: “It may be unusual to use a bacterium to get rid of another, but in the light of the looming threat from drug resistant infections the potential of beneficial bacteria-animal interactions should not be overlooked. We are increasingly relying on last line antibiotics, and this innovative study demonstrates how predatory bacteria could be an important additional tool to drugs in the fight against resistance.”
The Latest on: Living antibiotic
[google_news title=”” keyword=”living antibiotic” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Living antibiotic
- Antibiotic shortage hampers treatment of infectious kidney disease in Yarrabahon November 29, 2023 at 5:05 pm
There is a global supply shortage of the antibiotic used to treat APSGN The antibiotic is also used to treat health issues disproportionately affecting Aboriginal and Torres Strait Islander ...
- ‘I’ve tried and tried, and I can’t get rid of it’: The women living with drug-resistant infectionson November 29, 2023 at 4:03 am
Caroline Sampson, 60, contracted an antibiotic-resistant urinary tract infection (UTI) in 2016 after undergoing a minor gynaecological procedure. Almost seven years on with little respite, she says ...
- Family credits antibiotic with saving their dog's life amid mystery respiratory illnesson November 28, 2023 at 8:30 am
The Oliver family's golden retriever was hospitalized for several days. As cases of serious respiratory illness affecting dogs remain on the rise across the country, one family is sharing how an ...
- Pope Francis getting antibiotics intravenously for lung problem, limiting appointments, Vatican sayson November 27, 2023 at 5:18 am
Pope Francis is receiving antibiotics intravenously to treat a lung inflammation and will scale back some appointments, but he doesn’t have pneumonia or fever, the Vatican said Monday. Francis himself ...
- Antibiotic resistance is a threat to humanity, yet we have no idea exactly how big the problem is in Australiaon November 26, 2023 at 4:01 pm
A selection of pharmacists across NSW have been licensed this year to prescribe antibiotics to women suffering suspected urinary tract infections, or UTIs. The trial program mirrors similar ...
- Antibiotic resistance can be preventedon November 26, 2023 at 4:01 pm
These infections are becoming more difficult to treat yet there are no new antibiotics being developed. Discovering new antibiotics and bringing them to market is a formidable challenge. It can take ...
- 10 facts about antibiotic overuseon November 23, 2023 at 4:01 pm
Their misuse and overuse presents a looming threat: antibiotic resistance. What is Antibiotic Resistance? Antibiotic resistance happens when bacteria evolve to withstand the effects of antibiotics ...
- Scientists create living phlegm replica to study cystic fibrosis infectionson November 21, 2023 at 7:10 pm
Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.
- Antibiotic Resistance Kills 5 Million People Every Yearon November 21, 2023 at 11:34 am
Explore the rising crisis of antimicrobial resistance. From antibiotic abuse to its role in pandemics, uncover the global impact and solutions.
via Bing News